Viaderma IncOTC Pink - Current Information:VDRM
- LAST PRICE0.0097
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.0093/ 1,300
- Ask / Lots0.0096/ 425
- Open / Previous Close0.0000 / 0.0097
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Time | Volume | VDRM |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Viaderma Inc | 11.9M | 0.0x | --- |
Emmaus Life Sciences Inc | 5.4M | -1.1x | --- |
Agile Therapeutics Inc | 2.7M | 0.0x | --- |
SQZ Biotechnologies Co | 1.4M | 0.0x | --- |
Response Genetics Inc | 40.0 | 0.0x | --- |
Eiger BioPharmaceuticals Inc | 4.5M | -0.1x | --- |
Company Information
ViaDerma, Inc. is a specialty pharmaceutical company engaged in bringing new products to market and licensing its transdermal drug delivery technology solutions. The Company’s lead product is a topical antibiotic, which is focused on being sold under the brand name Vitastem. In addition to licensing its proprietary transdermal technologies, its lead product, Vitastem, is available for treating multiple skin conditions and ailments. The Company also has products in development in fields, such as anti-aging skin care, pain management, hair-loss, and toenail fungus. The products are based on a delivery system technology that allows for rapid mass transfer of the pharmaceutical active ingredient across the skin and into the body to provide immediate localized therapy. The Company’s products are sold to local medical practitioners and patients in clinics primarily in the Los Angeles, California area. The Company’s subsidiary is ViaDerma, II Inc.
Contact Information
- Headquarters
- 4640 Admiralty Way Ste 500MARINA DEL REY, CA, United States 90292-6636
- Phone
- 310-496-5744
- Fax
- 310-943-1457
Executives
- Chairman of the Board
- Chris Otiko
- President, Chief Executive Officer, Director
- Rui Sheng Liu
- Chief Financial Officer, Director
- Qing Hua Lin
- Manager - Production
- Shaowen Zhang
- Chief Sales Officer
- Baotang Zhao
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $11.9M |
|---|---|
Revenue (TTM) | $17.8M |
Shares Outstanding | 1.2B |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.05 |
EPS | $16.84 |
Book Value | $244.39 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 0.7 |
Price/Cash Flow (TTM) | 2.2x |
Operating Margin | 21.02% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
